A novel model of persistent retinal neovascularization for the development of sustained anti-VEGF therapies.
Exp Eye Res
; 174: 98-106, 2018 09.
Article
in En
| MEDLINE
| ID: mdl-29852133
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Retinal Neovascularization
/
Angiogenesis Inhibitors
/
Receptors, Vascular Endothelial Growth Factor
/
Vascular Endothelial Growth Factor A
/
Bevacizumab
/
Ranibizumab
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Exp Eye Res
Year:
2018
Document type:
Article
Country of publication:
Reino Unido